[Clinical management of hemolytic-uremic syndrome and thrombotic-thrombocytopenic purpura].

@article{Keller1994ClinicalMO,
  title={[Clinical management of hemolytic-uremic syndrome and thrombotic-thrombocytopenic purpura].},
  author={Frieder Keller and Hartmut Schwarze and Anja Schwarz},
  journal={Wiener klinische Wochenschrift},
  year={1994},
  volume={106 19},
  pages={603-7}
}
BACKGROUND According to recent research, the hemolytic-uremic syndrome (HUS) and thrombotic-thrombocytopenic purpura (TTP) are variable expressions of the same entity (HUS-TTP) with a common pathomechanism (endothelial cell damage, microthrombi) and common treatment (plasma infusion, plasmapheresis). The condition is still serious with a poor prognosis, and… CONTINUE READING